STME
STIMCELL ENERGETICS INC.
Price Chart
Latest Quote
$0.35
| Previous Close | $0.35 |
| Open | $0.29 |
| Day High | $0.29 |
| Day Low | $0.29 |
| Volume | 1,435 |
Stock Information
| Shares Outstanding | 21.14M |
| Total Debt | $769K |
| Cash Equivalents | $10K |
| Net Income | $-885K |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $7.34M |
| EPS (TTM) | $-0.04 |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $8.10M |
| Income | $-885K |
| Book/sh | $-0.08 |
| Cash/sh | $0.00 |
Financial Ratios
| Quick Ratio | 0.01 |
| Current Ratio | 0.02 |
Returns & Margins
| ROA | -2153.11% |
Ownership
| Insider Ownership | 71.67% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -17.37 |
| P/B | -4.34 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.33 |
| SMA50 | $0.32 |
| SMA200 | $0.35 |
| RSI | 97.44 |
| ATR | 0.0043 |
| Shares Float | 5.91M |
| Volatility | 44.83 |
| Rel Volume | 1.78 |
Performance History
| Week | -0.44% |
| Month | +16.95% |
| Quarter | +15.75% |
| 6 Months | +5.26% |
| YTD | -13.16% |
| Year | -27.62% |
| 3 Years | +1097.76% |
| 5 Years | +24.05% |
| 10 Years | +24.05% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-12 | $0.35 | 200 |
| 2026-06-11 | $0.35 | 0 |
| 2026-06-10 | $0.35 | 0 |
| 2026-06-09 | $0.35 | 0 |
| 2026-06-08 | $0.35 | 0 |
| 2026-06-05 | $0.35 | 0 |
| 2026-06-04 | $0.35 | 0 |
| 2026-06-03 | $0.35 | 0 |
| 2026-06-02 | $0.35 | 0 |
| 2026-06-01 | $0.35 | 0 |
| 2026-05-29 | $0.35 | 0 |
| 2026-05-28 | $0.35 | 1,000 |
| 2026-05-27 | $0.32 | 500 |
| 2026-05-26 | $0.29 | 208 |
| 2026-05-22 | $0.29 | 100 |
| 2026-05-21 | $0.29 | 0 |
| 2026-05-20 | $0.29 | 0 |
| 2026-05-19 | $0.29 | 0 |
| 2026-05-18 | $0.29 | 242 |
| 2026-05-15 | $0.30 | 0 |
| 2026-05-14 | $0.30 | 0 |
| 2026-05-13 | $0.30 | 0 |
About STIMCELL ENERGETICS INC.
StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions in the United States. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Cell MedX Corp. and changed its name to StimCell Energetics Inc. in November 2024. StimCell Energetics Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
đ° Latest News
Income Statement (Annual)
| Metric | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $2,762 | $6,065 |
| Operating Revenue | $0 | $0 | $2,762 | $6,065 |
| Reconciled Cost Of Revenue | - | $0 | $2,279 | $2,032 |
| Cost Of Revenue | - | $0 | $2,279 | $2,032 |
| Expenses | ||||
| Interest Expense | $38,256 | $61,651 | - | - |
| Total Expenses | $504,949 | $261,270 | $450,420 | $677,758 |
| Other Income Expense | $-23,088 | $180,435 | - | - |
| Net Non Operating Interest Income Expense | $-38,256 | $-61,651 | $-47,384 | $-25,686 |
| Total Other Finance Cost | $38,256 | $61,651 | $47,384 | $25,686 |
| Interest Expense Non Operating | $38,256 | $61,651 | - | - |
| Operating Expense | $504,949 | $261,270 | $448,141 | $675,726 |
| Other Operating Expenses | $90,000 | $37,500 | - | - |
| General And Administrative Expense | $350,940 | $246,309 | $358,921 | $523,872 |
| Selling And Marketing Expense | - | - | - | $0 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-566,293 | $-142,486 | $-495,042 | $-697,379 |
| Net Interest Income | $-38,256 | $-61,651 | $-47,384 | $-25,686 |
| Normalized Income | $-543,205 | $-322,921 | $-495,042 | $-697,379 |
| Net Income From Continuing And Discontinued Operation | $-566,293 | $-142,486 | $-495,042 | $-697,379 |
| Net Income Common Stockholders | $-566,293 | $-142,486 | $-495,042 | $-697,379 |
| Net Income | $-566,293 | $-142,486 | $-495,042 | $-697,379 |
| Net Income Including Noncontrolling Interests | $-566,293 | $-142,486 | $-495,042 | $-697,379 |
| Net Income Continuous Operations | $-566,293 | $-142,486 | $-495,042 | $-697,379 |
| Pretax Income | $-566,293 | $-142,486 | $-495,042 | $-697,379 |
| Special Income Charges | $-5,931 | $187,517 | $0 | $0 |
| Operating Income | $-504,949 | $-261,270 | $-447,658 | $-671,693 |
| Gross Profit | - | $0 | $483 | $4,033 |
| Depreciation Amortization Depletion Income Statement | - | - | $0 | $1,145 |
| Depreciation And Amortization In Income Statement | - | - | $0 | $1,145 |
| Depreciation Income Statement | - | - | $0 | $1,145 |
| Per Share | ||||
| Diluted EPS | $-0.03 | $-0.01 | $-0.15 | $-0.15 |
| Basic EPS | $-0.03 | $-0.01 | $-0.15 | $-0.15 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-504,949 | $-261,270 | $-447,658 | $-670,548 |
| Total Unusual Items | $-23,088 | $180,435 | $0 | $0 |
| Total Unusual Items Excluding Goodwill | $-23,088 | $180,435 | $0 | $0 |
| EBITDA (Bullshit earnings) | $-528,037 | $-80,835 | $-447,658 | $-670,548 |
| EBIT | $-528,037 | $-80,835 | $-447,658 | $-671,693 |
| Diluted Average Shares | $19,843,258 | $10,733,896 | $4,194,870 | $4,186,587 |
| Basic Average Shares | $19,843,258 | $10,733,896 | $4,194,870 | $4,186,587 |
| Diluted NI Availto Com Stockholders | $-566,293 | $-142,486 | $-495,042 | $-697,379 |
| Other Special Charges | $5,931 | $-187,517 | - | - |
| Gain On Sale Of Security | $-17,157 | $-7,082 | - | - |
| Research And Development | $64,009 | $-22,539 | $89,220 | $150,709 |
| Selling General And Administration | $350,940 | $246,309 | $358,921 | $523,872 |
| Other Gand A | $350,940 | $246,309 | $358,921 | $523,872 |
| Reconciled Depreciation | - | - | $0 | $1,145 |
| Write Off | - | - | - | $0 |
Balance Sheet (Annual)
| Metric | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,246,286 | $-826,455 | $-2,385,480 | $-2,009,031 |
| Total Assets | $21,222 | $46,122 | $103,270 | $41,344 |
| Total Non Current Assets | $0 | $0 | $0 | $0 |
| Current Assets | $21,222 | $46,122 | $103,270 | $41,344 |
| Other Current Assets | $6,641 | $2,707 | - | - |
| Cash Cash Equivalents And Short Term Investments | $14,581 | $43,415 | $98,295 | $24,380 |
| Cash And Cash Equivalents | $14,581 | $43,415 | $98,295 | $24,380 |
| Cash Financial | $14,581 | $43,415 | $98,295 | $24,380 |
| Prepaid Assets | - | $900 | $1,750 | $8,189 |
| Receivables | - | $1,807 | $3,225 | $8,775 |
| Taxes Receivable | - | $1,807 | $3,225 | $8,775 |
| Inventory | - | - | - | - |
| Debt | ||||
| Net Debt | $444,391 | $270,075 | $902,729 | $592,401 |
| Total Debt | $458,972 | $313,490 | $1,001,024 | $616,781 |
| Current Debt And Capital Lease Obligation | $458,972 | $313,490 | $1,001,024 | $616,781 |
| Current Debt | $458,972 | $313,490 | $1,001,024 | $616,781 |
| Other Current Borrowings | $458,972 | $313,490 | $835,415 | $505,893 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,267,508 | $872,577 | $2,488,750 | $2,050,375 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $0 | $0 |
| Current Liabilities | $1,267,508 | $872,577 | $2,488,750 | $2,050,375 |
| Payables And Accrued Expenses | $808,536 | $559,087 | $1,487,726 | $1,433,594 |
| Payables | $781,582 | $531,029 | $1,451,166 | $1,404,717 |
| Accounts Payable | $322,144 | $288,891 | $408,264 | $442,439 |
| Current Notes Payable | - | $0 | $165,609 | $110,888 |
| Equity | ||||
| Common Stock Equity | $-1,246,286 | $-826,455 | $-2,385,480 | $-2,009,031 |
| Total Equity Gross Minority Interest | $-1,246,286 | $-826,455 | $-2,385,480 | $-2,009,031 |
| Stockholders Equity | $-1,246,286 | $-826,455 | $-2,385,480 | $-2,009,031 |
| Gains Losses Not Affecting Retained Earnings | $448,538 | $435,491 | $431,673 | $313,080 |
| Other Equity Adjustments | $448,538 | $435,491 | $431,673 | $313,080 |
| Retained Earnings | $-10,861,556 | $-10,295,263 | $-10,152,777 | $-9,657,735 |
| Other | ||||
| Ordinary Shares Number | $20,141,272 | $19,815,758 | $4,194,870 | $4,194,870 |
| Share Issued | $20,141,272 | $19,815,758 | $4,194,870 | $4,194,870 |
| Tangible Book Value | $-1,246,286 | $-826,455 | $-2,385,480 | $-2,009,031 |
| Invested Capital | $-787,314 | $-512,965 | $-1,384,456 | $-1,392,250 |
| Working Capital | $-1,246,286 | $-826,455 | $-2,385,480 | $-2,009,031 |
| Total Capitalization | $-1,246,286 | $-826,455 | $-2,385,480 | $-2,009,031 |
| Additional Paid In Capital | $9,146,591 | $9,013,501 | $7,272,701 | $7,272,701 |
| Capital Stock | $20,141 | $19,816 | $62,923 | $62,923 |
| Common Stock | $20,141 | $19,816 | $62,923 | $62,923 |
| Current Accrued Expenses | $26,954 | $28,058 | $36,560 | $28,877 |
| Dueto Related Parties Current | $459,438 | $242,138 | $1,042,902 | $962,278 |
| Net PPE | - | - | - | $0 |
| Gross PPE | - | - | - | $0 |
| Other Properties | - | - | - | - |
| Machinery Furniture Equipment | - | - | - | - |
Cash Flow Statement (Annual)
| Metric | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-141,600 | $-145,898 | $-272,209 | $-450,591 |
| Operating Activities | ||||
| Operating Cash Flow | $-141,600 | $-145,898 | $-272,209 | $-450,591 |
| Cash Flow From Continuing Operating Activities | $-141,600 | $-145,898 | $-272,209 | $-450,591 |
| Operating Gains Losses | $21,272 | $-181,137 | $71,141 | $44,906 |
| Investing Activities | ||||
| Investing Cash Flow | - | - | - | $0 |
| Cash Flow From Continuing Investing Activities | - | - | - | $0 |
| Capital Expenditure | - | - | - | - |
| Financing Activities | ||||
| Financing Cash Flow | $112,858 | $91,033 | $346,364 | $453,971 |
| Cash Flow From Continuing Financing Activities | $112,858 | $91,033 | $346,364 | $453,971 |
| Net Other Financing Charges | - | $75,000 | - | $160,000 |
| Other | ||||
| Issuance Of Debt | $112,858 | $16,033 | $346,364 | $293,971 |
| End Cash Position | $14,581 | $43,415 | $98,295 | $24,380 |
| Beginning Cash Position | $43,415 | $98,295 | $24,380 | $20,753 |
| Effect Of Exchange Rate Changes | $-92 | $-15 | $-240 | $247 |
| Changes In Cash | $-28,742 | $-54,865 | $74,155 | $3,380 |
| Net Issuance Payments Of Debt | $112,858 | $16,033 | $346,364 | $293,971 |
| Net Long Term Debt Issuance | $112,858 | $16,033 | $346,364 | $293,971 |
| Long Term Debt Issuance | $112,858 | $16,033 | $346,364 | $293,971 |
| Change In Working Capital | $257,415 | $116,074 | $104,308 | $137,976 |
| Change In Other Current Assets | $-3,930 | $2,278 | $11,408 | $12,210 |
| Change In Payables And Accrued Expense | $261,345 | $113,796 | $92,900 | $125,766 |
| Change In Accrued Expense | $-1,108 | $-8,500 | $7,770 | $-6,302 |
| Change In Payable | $262,453 | $122,296 | $85,130 | $132,068 |
| Change In Account Payable | $42,857 | $46,750 | $-14,064 | $19,953 |
| Other Non Cash Items | $146,006 | $61,651 | $47,384 | $62,761 |
| Net Foreign Currency Exchange Gain Loss | $15,341 | $6,380 | $71,141 | $44,906 |
| Net Income From Continuing Operations | $-566,293 | $-142,486 | $-495,042 | $-697,379 |
| Depreciation Amortization Depletion | - | - | $0 | $1,145 |
| Depreciation And Amortization | - | - | $0 | $1,145 |
| Depreciation | - | - | $0 | $1,145 |
| Net PPE Purchase And Sale | - | - | - | $0 |
| Purchase Of PPE | - | - | - | $0 |
| Change In Inventory | - | - | - | $0 |
| Asset Impairment Charge | - | - | - | $0 |
| Amortization Cash Flow | - | - | - | - |
| Amortization Of Intangibles | - | - | - | - |